R2 Technology
This article was originally published in The Gray Sheet
Executive Summary
Board member William Mercer will serve as interim president/CEO of the computer-aided detection (CAD) firm until a permanent successor is found for outgoing chief exec Michael Klein, who has resigned. "As we strive to take R2 Technology towards its next phase as a full-fledged medical software company requiring heavy involvement in the soft copy or digital environment, Mike and the board agreed that the next generation of leadership would be needed," Mercer explained June 9. Mercer is a former president and CEO of Alaris Medical. R2, which provides CAD systems for breast cancer detection and has grown sales from $5 mil. to nearly $60 mil. over the past four years, received an FDA approvable letter for its ImageChecker CT lung nodule CAD system in April (1"The Gray Sheet" April 19, 2004, p. 26)...